Stevenage, United Kingdom

Ian Edward David Smith

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ian Edward David Smith: Innovator in Biopharmaceuticals

Introduction

Ian Edward David Smith is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of biopharmaceuticals, holding a total of 5 patents. His work primarily focuses on the development of compounds and methods that target specific proteins for therapeutic purposes.

Latest Patents

One of his latest patents is titled "Conjugates comprising RIPK2 inhibitors." This invention relates to compounds, compositions, combinations, and medicaments that contain these compounds, along with processes for their preparation. The invention also discusses the use of these compounds in inhibiting the activity of RIP2 kinase, particularly for treating inflammatory diseases or conditions.

Another significant patent is "Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase." This invention involves bifunctional compounds that serve as modulators of targeted ubiquitination. These compounds are designed to bind to a ubiquitin ligase on one end and a target protein on the other, facilitating the degradation and inhibition of that protein. The invention showcases a broad range of pharmacological activities associated with these compounds.

Career Highlights

Ian has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and Yale University. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Ian has collaborated with notable colleagues such as John David Harling and Afjal Hussain Miah. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Ian Edward David Smith is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in the treatment of diseases. His innovative patents and collaborations reflect his commitment to improving healthcare through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…